Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.31 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19924608 | 1.00 | MEN1 (0.36) | MEN1KMT2AHTTL3MBTL1TSHR | |
| SCHEMBL9191326 | 1.00 | MEN1 (0.36) | MEN1KMT2AHTTL3MBTL1TSHR | |
| SCHEMBL3912889 | 1.00 | MEN1 (0.36) | MEN1KMT2AHTTL3MBTL1TSHR | |
| SCHEMBL21402635 | 0.87 | MEN1 (0.36) | MEN1KMT2AHTTL3MBTL1TSHR | |
| SCHEMBL8208362 | 0.85 | MEN1 (0.35) | MEN1KMT2AHTTL3MBTL1TSHR | |
| SCHEMBL9186431 | 0.84 | MEN1 (0.33) | MEN1KMT2AHTTL3MBTL1SMN1; SMN2 | |
| SCHEMBL9192141 | 0.84 | MEN1 (0.33) | MEN1KMT2AHTTL3MBTL1SMN1; SMN2 | |
| SCHEMBL9190973 | 0.84 | MEN1 (0.33) | MEN1KMT2AHTTL3MBTL1SMN1; SMN2 | |
| SCHEMBL9188490 | 0.83 | MAPK1 (0.36) | MEN1KMT2AHTTL3MBTL1 | |
| SCHEMBL9187798 | 0.83 | MAPK1 (0.36) | MEN1KMT2AHTTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | claimed |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | GLYCOSCIENCE, S.L. (ES) | 2025-12-30 | — | — | US | claimed |
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| CN-120078656-A | Fragrance durability improver and preparation method thereof, essence and shampoo product | 森富(广东)科技有限公司 | 2025-06-03 | — | — | CN | claimed |
| WO-2025104977-A1 | NOVEL ALDEHYDE COMPOUND | 花王株式会社 | 2025-05-22 | — | — | WO | claimed |
| CN-115427421-B | 3' -Ketoglycoside compounds for slow release of volatile alcohols | 格莱克科学有限公司 | 2025-04-01 | — | — | CN | claimed |
| WO-2025051371-A1 | A FRAGRANCE PASTILLE | SYMRISE AG (DE) | 2025-03-13 | — | — | WO | claimed |
| WO-2025045354-A1 | A FRAGRANCE TABLET | SYMRISE AG (DE) | 2025-03-06 | — | — | WO | claimed |
| EP-1029032-B1 | LAUNDRY TREATMENT PRODUCTS FOR SPANDEX CONTAINING FABRICS | UNILEVER PLC (GB) | 2004-03-03 | — | — | EP | claimed |
| US-6369248-B1 | HYDROXY ESTERS FOR PERFUMES | GIVAUDAN SA (CH) | 2002-04-09 | — | — | US | claimed |
| US-6262287-B1 | POLYSILOXANE OLIGOMERS | GIVAUDAN-ROURE (INTERNATIONAL) SA (CH) | 2001-07-17 | — | — | US | claimed |
| EP-1021160-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL NEDERLAND BV (NL) | 2000-07-26 | — | — | EP | claimed |
| EP-0989970-A1 | FRAGRANCE PRECURSOR COMPOUNDS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 2000-04-05 | — | — | EP | claimed |
| EP-0980863-A1 | Oxime carboxylic acid derivatives | Givaudan Roure (International) S.A. (CH) | 2000-02-23 | — | — | EP | claimed |
| EP-0953562-A1 | Beta, gamma-unsaturated delta-keto esters | Givaudan Roure (International) S.A. (CH) | 1999-11-03 | — | — | EP | claimed |
| WO-1999018926-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL B.V. (NL) | 1999-04-22 | — | — | WO | claimed |
| WO-1998058899-A1 | FRAGRANCE PRECURSOR COMPOUNDS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-12-30 | — | — | WO | claimed |
| EP-0878497-A2 | Fragrance precursor compounds | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-11-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | MEN1 3398/4885KMT2A 2244/4885HTT 3831/4885 |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | EBP, MGAT1, MGAT3 | MEN1 3970/4885KMT2A 1805/4885HTT 4029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.